Kenneth Gordon to Keratolytic Agents
This is a "connection" page, showing publications Kenneth Gordon has written about Keratolytic Agents.
Connection Strength
0.365
-
Comparative tolerability of systemic treatments for plaque-type psoriasis. Drug Saf. 2002; 25(13):913-27.
Score: 0.212
-
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet. 2008 May 17; 371(9625):1665-74.
Score: 0.082
-
The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach. J Am Acad Dermatol. 2006 Mar; 54(3 Suppl 2):S85-91.
Score: 0.071